A trial has found that an experimental mRNA flu vaccine is more effective than a conventional flu shot, but it also causes more side effects. The results of the trial have been reported in several medical and scientific outlets, with some noting the vaccine's efficacy, immunogenicity, and safety. A key FDA committee has unanimously recommended the vaccine, although it is unclear which specific vaccine was recommended or when it may be available.